Amgen (AMGN) FCF Margin (2009 - 2026)

Amgen (AMGN) has reported FCF Margin for 18 consecutive years, with 17.14% the latest figure, recorded in Q1 2026.

• In Q1 2026, FCF Margin rose 511.0% year-over-year to 17.14%; the TTM figure through Mar 2026 stood at 23.1% (down 889.0% YoY), while the FY2025 annual figure was 22.04%, down 906.0% from the prior year.
• FCF Margin came in at 17.14% for Q1 2026 at Amgen, up from 9.74% in the prior quarter.
• The five-year high for FCF Margin was 503.05% in Q4 2022, with the low at 3.53% in Q4 2023.
• Average FCF Margin over 5 years is 54.91%, with a median of 26.48% recorded in 2024.
• Across the five-year window, FCF Margin jumped 46623 bps in 2022 and sank 49952 bps in 2023, its largest moves.
• Year by year, FCF Margin stood at 503.05% in 2022, then slumped by 99 bps to 3.53% in 2023, then soared by 1273 bps to 48.43% in 2024, then sank by 80 bps to 9.74% in 2025, then soared by 76 bps to 17.14% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 17.14%, 9.74%, and 44.45% for Q1 2026, Q4 2025, and Q3 2025 respectively.